TCT-99 Clinical Outcomes in Patients With High Bleeding Risk and Bifurcations After Percutaneous Coronary Intervention With Resolute Onyx and 1-Month Dual Antiplatelet Therapy

Clinical Outcomes ◽

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk

Circulation Journal ◽

10.1253/circj.cj-20-1058 ◽

2021 ◽

Cited By ~ 1

Author(s):

Masato Nakamura ◽

Kazushige Kadota ◽

Koichi Nakao ◽

Yoshihisa Nakagawa ◽

Junya Shite ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy

JAMA Cardiology ◽

10.1001/jamacardio.2020.0285 ◽

2020 ◽

Vol 5 (8) ◽

pp. 939 ◽

Cited By ~ 2

Author(s):

Roxana Mehran ◽

Jaya Chandrasekhar ◽

Philip Urban ◽

Irene M. Lang ◽

Ute Windhoevel ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Abbreviated Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in High Bleeding Risk Patients

Interventional Cardiology Clinics ◽

10.1016/j.iccl.2020.06.002 ◽

2020 ◽

Vol 9 (4) ◽

pp. 441-449

Author(s):

Matthew J. Price

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Risk Patients ◽

Monotherapy With Prasugrel After Dual-Antiplatelet Therapy for Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk　― A Prospective Cohort Study (PENDULUM mono Study) ―

Circulation Journal ◽

10.1253/circj.cj-20-0786 ◽

2020 ◽

Vol 85 (1) ◽

pp. 27-36 ◽

Cited By ~ 1

Author(s):

Masato Nakamura ◽

Yoshihiro Morino ◽

Tsunekazu Kakuta ◽

Yoshiki Hata ◽

Itaru Takamisawa ◽

...

Keyword(s):

Cohort Study ◽

Antiplatelet Therapy ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Bleeding Risk ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Treated With Short Dual Antiplatelet Therapy: A Recre8 Subanalysis

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2021.06.048 ◽

2021 ◽

Vol 28 ◽

pp. S20-S21

Author(s):

Nicole D. van Hemert ◽

Michiel Voskuil ◽

Rik Rozemeijer ◽

Mèra Stein ◽

Peter Frambach ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Bleeding Risk ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Drug Eluting ◽

Faculty Opinions recommendation of Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158593.618791 ◽

2009 ◽

Author(s):

Ian Beales

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Mo1276 – No Differences in Gi Bleeding Risk Between Clopidogrel-, Ticagrelor- Or Prasugrel- Based Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Gastroenterology ◽

10.1016/s0016-5085(19)38791-8 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-743

Author(s):

Viviana Laredo ◽

Sandra Garcia ◽

Nuria Saura ◽

Maria Hernandez Ainsa ◽

Patricia Carrera ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Bleeding Risk ◽

Coronary Intervention ◽

Gi Bleeding ◽

Impact of Proton-pump Inhibitors on the Pharmacodynamic Effect and Clinical Outcomes in Patients Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention

Chinese Medical Journal ◽

10.4103/0366-6999.220304 ◽

2017 ◽

Vol 130 (24) ◽

pp. 2899-2905 ◽

Cited By ~ 5

Author(s):

Pei Zhu ◽

Zhan Gao ◽

Xiao-Fang Tang ◽

Jing-Jing Xu ◽

Yin Zhang ◽

...

Keyword(s):

Clinical Outcomes ◽

Antiplatelet Therapy ◽

Proton Pump Inhibitors ◽

Proton Pump ◽

Coronary Intervention ◽

Pharmacodynamic Effect ◽

Impact of dual antiplatelet therapy duration on 1‐year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real‐world OPT‐CAD study

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.28653 ◽

2019 ◽

Vol 95 (S1) ◽

pp. 579-586 ◽

Cited By ~ 1

Author(s):

Jing Li ◽

Yi Li ◽

Miaohan Qiu ◽

Zhiguo Li ◽

Jing Yang ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Outcomes ◽

Antiplatelet Therapy ◽

Real World ◽

Coronary Intervention ◽

Diabetic Patients ◽

Coronary Syndrome ◽

Clinical Outcomes After Dual Antiplatelet Therapy Cessation at One Month Among Troponin-Negative Patients Undergoing Percutaneous Coronary Intervention: A Subanalysis of the Recre8 Trial

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2021.06.034 ◽

2021 ◽

Vol 28 ◽

pp. S14-S15

Author(s):

Nicole D. van Hemert ◽

Michiel Voskuil ◽

Rik Rozemeijer ◽

Mèra Stein ◽

Peter Frambach ◽

...

Keyword(s):

Clinical Outcomes ◽

Antiplatelet Therapy ◽

Coronary Intervention ◽